Health Minister reviews availability of COVID-19 essential drugs 

Raw materials for the drugs are available in enough quantities

The Union Minister for Health and Family Welfare and Chemicals and Fertilizers, Mansukh Mandaviya, yesterday reviewed the supply and availability of COVID-19-related essential medicines in the country.

During the review, it was noted that sufficient stocks of all the essential medicines are available. Raw materials for these drugs are also available in enough quantities.

The strategic buffer stock has been created for eight drugs (Tocilizumab, Methyl Predinisolone, Enaxopirin, Dexamethasone, Remdesivir, Amphotericin B Deoxycholate, Posaconazole and Intravenous Immunoglobilin), all of which are available in the country.

Senior officials of the Ministry of Health and Family Welfare were also present in the review meeting.

COVID-19 essential drugsMansukh MandaviyaMinistry of HealthremdesivirTocilizumab
Comments (0)
Add Comment